低危患者经导管与外科主动脉瓣置换的超声心动图结果:PARTNER 3 试验
PARTNER 3 试验将 1000 例重度主动脉瓣狭窄且外科低危患者随机分配至经股动脉球囊扩张瓣膜 TAVR 或 SAVR,比较基线、30 天和 1 年超声心动图。TAVR 组中度或重度主动脉瓣反流比例与 SAVR 相似,但轻度反流更多;1 年时跨瓣压差、瓣口面积和重度患者-人工瓣膜不匹配比例相似,SAVR 组右室收缩功能减退及三尖瓣反流加重。
要点
- 低危重度主动脉瓣狭窄患者中,TAVR 与 SAVR 的中度或重度主动脉瓣反流比例无显著差异。
- TAVR 组轻度主动脉瓣反流更多见,但 1 年跨瓣压差、瓣口面积及重度患者-人工瓣膜不匹配比例与 SAVR 相似。
- SAVR 与右室收缩功能减退及三尖瓣反流加重相关,且持续至 1 年。
核心结论
- 在重度主动脉瓣狭窄且外科低危患者中,使用 SAPIEN 3 瓣膜的 TAVR 与 SAVR 相比,中度或重度主动脉瓣反流比例相似但轻度主动脉瓣反流比例更高;跨瓣压差、瓣口面积、重度患者-人工瓣膜不匹配比例及左室质量消退相似;SAVR 与右室收缩功能显著减退及三尖瓣反流加重相关并持续至 1 年;高 Zva 和低 TAPSE 与 1 年不良结局相关,而主动脉瓣反流和重度患者-人工瓣膜不匹配则不然。
研究设计与样本
- PARTNER 3 试验将 1000 例重度主动脉瓣狭窄且外科低危患者随机分配至经股动脉球囊扩张瓣膜 TAVR 或 SAVR。
- 基线、30 天和 1 年经胸超声心动图由 2 个超声心动图核心实验室联盟分析。
主要发现
- 30 天中度或重度主动脉瓣反流比例 TAVR 组 0.8% 对 SAVR 组 0.2%(P=0.38),无统计学差异。
- 30 天轻度主动脉瓣反流 TAVR 组 28.8% 高于 SAVR 组 4.2%(P<0.001)。
- 1 年平均跨瓣压差 TAVR 组 13.7±5.6 mmHg 对 SAVR 组 11.6±5.0 mmHg(P=0.12),瓣口面积 1.72±0.37 cm2 对 1.76±0.42 cm2(P=0.12)。
- 30 天重度患者-人工瓣膜不匹配比例 TAVR 组 4.6% 对 SAVR 组 6.3%(P=0.30)。
- 1 年 Zva TAVR 组 3.7±0.8 mmHg/mL/m2 低于 SAVR 组 3.9±0.9 mmHg/mL/m2(P<0.001)。
临床怎么用
- 对于外科低危重度主动脉瓣狭窄患者,TAVR 与 SAVR 在主动脉瓣反流、跨瓣压差、瓣口面积及重度患者-人工瓣膜不匹配方面总体相似,但 TAVR 轻度主动脉瓣反流更常见。
- SAVR 术后需关注右室收缩功能减退及三尖瓣反流加重,并持续至 1 年。
- 高 Zva 和低 TAPSE 与 1 年不良结局相关,或可作为风险分层参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to compare echocardiographic findings in low-risk patients with severe aortic stenosis after surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). METHODS: The PARTNER 3 trial (Placement of Aortic Transcatheter Valves) randomized 1000 patients with severe aortic stenosis and low surgical risk to undergo either transfemoral TAVR with the balloon-expandable SAPIEN 3 valve or SAVR. Transthoracic echocardiograms obtained at baseline and at 30 days and 1 year after the procedure were analyzed by a consortium of 2 echocardiography core laboratories. RESULTS: The percentage of moderate or severe aortic regurgitation (AR) was low and not statistically different between the TAVR and SAVR groups at 30 days (0.8% versus 0.2%; P=0.38). Mild AR was more frequent after TAVR than SAVR at 30 days (28.8% versus 4.2%; P<0.001). At 1 year, mean transvalvular gradient (13.7±5.6 versus 11.6±5.0 mm Hg; P=0.12) and aortic valve area (1.72±0.37 versus 1.76±0.42 cm2; P=0.12) were similar in TAVR and SAVR. The percentage of severe prosthesis-patient mismatch at 30 days was low and similar between TAVR and SAVR (4.6 versus 6.3%; P=0.30). Valvulo-arterial impedance (Zva), which reflects total left ventricular hemodynamic burden, was lower with TAVR than SAVR at 1 year (3.7±0.8 versus 3.9±0.9 mm Hg/mL/m2; P<0.001). Tricuspid annulus plane systolic excursion decreased and the percentage of moderate or severe tricuspid regurgitation increased from baseline to 1 year in SAVR but remained unchanged in TAVR. Irrespective of treatment arm, high Zva and low tricuspid annulus plane systolic excursion, but not moderate to severe AR or severe prosthesis-patient mismatch, were associated with increased risk of the composite end point of mortality, stroke, and rehospitalization at 1 year. CONCLUSIONS: In patients with severe aortic stenosis and low surgical risk, TAVR with the SAPIEN 3 valve was associated with similar percentage of moderate or severe AR compared with SAVR but higher percentage of mild AR. Transprosthetic gradients, valve areas, percentage of severe prosthesis-patient mismatch, and left ventricular mass regression were similar in TAVR and SAVR. SAVR was associated with significant deterioration of right ventricular systolic function and greater tricuspid regurgitation, which persisted at 1 year. High Zva and low tricuspid annulus plane systolic excursion were associated with worse outcome at 1 year whereas AR and severe prosthesis-patient mismatch were not. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02675114.
引用
- Pibarot P, Salaun E, Dahou A, et al. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial. Circulation. 2020. PMID: 32272848. doi:10.1161/CIRCULATIONAHA.119.044574
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。